This product is a recombinant human antibody that recognizes A. fumigatus cell walls. The antibody was purified by affinity chromatography. It can be used in ELISA, IF.
Figure 1 mAbs show distinct localization patterns.
A. fumigatus 237 was grown for 12-14 h, fixed, incubated with primary mAb, followed by FITC-conjugated anti-mouse secondary antibody, Calcofluor White to label chitin and Hoechst 33258 to label nuclei. Primary antibodies: mAb1E2 (a), mAb8A1 (b) and mAb19H1 (c). Left column, FITC; right column, chitinous cell wall and nuclei. Arrows mark conidia; arrowheads mark septa; the double arrowhead marks a newly formed branch from main hypha.
Momany, M., Lindsey, R., Hill, T. W., Richardson, E. A., Momany, C., Pedreira, M., ... & Roberts, K. A. (2004). The Aspergillus fumigatus cell wall is organized in domains that are remodelled during polarity establishment. Microbiology, 150(10), 3261-3268.
Figure 2 Basal and apical wall domains do not overlap.
(a, b) A. fumigatus 237 was grown for 6 h, fixed and labelled with mAb8A1 (green) and mAb16C4 (red). Left column, differential interference contrast (DIC); middle column, mAb 8A1 followed by FITC-conjugated secondary antibody; right column, mAb 16C4 directly coupled to Alexa Fluor 546.
Momany, M., Lindsey, R., Hill, T. W., Richardson, E. A., Momany, C., Pedreira, M., ... & Roberts, K. A. (2004). The Aspergillus fumigatus cell wall is organized in domains that are remodelled during polarity establishment. Microbiology, 150(10), 3261-3268.
Figure 3 mAbs 8A1 and 16C4 recognize wall epitopes.
A. fumigatus germlings were plasmolysed in 2·67 M sorbitol before labelling with mAbs and visualization with FITC-conjugated anti-mouse secondary antibody. DIC and fluorescence images of germling labelled by mAb8A1 (a, b) or mAb16C4 (c, d). Bar, 5 μm.
Momany, M., Lindsey, R., Hill, T. W., Richardson, E. A., Momany, C., Pedreira, M., ... & Roberts, K. A. (2004). The Aspergillus fumigatus cell wall is organized in domains that are remodelled during polarity establishment. Microbiology, 150(10), 3261-3268.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for FAMAB-1576CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.